Literature DB >> 15824742

Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity.

Séverine Seemann1, Pierre Hainaut.   

Abstract

The p53 protein is redox-sensitive in vitro but in vivo effectors of this sensitivity are not known. In yeasts deficient for thioredoxin (Trx) reductase (TRR), p53 accumulates in an inactive, oxidized form, suggesting a role for TRR-Trx in controlling p53. In mammalian cells, p53 binds to redox factor-1 (APE/Ref-1), an enzyme containing an abasic endonuclease domain involved in base excision repair, and a thiol reductase domain recycled by Trx and involved in regulating the transcription factor AP-1. To evaluate the role of TRR and APE/Ref-1 in p53 regulation, we have abrogated their expression using RNA interference in cell lines expressing wild-type p53. Inhibition of TRR resulted in accumulation of oxidized Trx and increased levels and DNA-binding activity of p53, with no phosphorylation of Ser15 or Ser20. In contrast, inhibition of APE/Ref-1 accelerated p53 protein turnover, resulting in a decrease in p53 levels and activity. However, inhibition of either TRR or APE/Ref-1 did not prevent activation and accumulation of p53 in response to DNA-damage by doxorubicin. When both factors were inhibited, basal levels of p53 were restored. These results suggest that TRR-Trx and APE/Ref-1 cooperate in the control of basal p53 activity, but not in its induction by DNA-damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15824742     DOI: 10.1038/sj.onc.1208549

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

1.  Modulation of AP-endonuclease1 levels associated with hepatic cirrhosis in rat model treated with human umbilical cord blood mononuclear stem cells.

Authors:  Ahmad R Bassiouny; Amira Z Zaky; Shaymaa A Abdulmalek; Kamal M Kandeel; Alaa Ismail; Marie Moftah
Journal:  Int J Clin Exp Pathol       Date:  2011-10-16

Review 2.  Redox regulatory mechanisms in cellular stress responses.

Authors:  Nina Fedoroff
Journal:  Ann Bot       Date:  2006-06-21       Impact factor: 4.357

Review 3.  Redox-based regulation of signal transduction: principles, pitfalls, and promises.

Authors:  Yvonne M W Janssen-Heininger; Brooke T Mossman; Nicholas H Heintz; Henry J Forman; Balaraman Kalyanaraman; Toren Finkel; Jonathan S Stamler; Sue Goo Rhee; Albert van der Vliet
Journal:  Free Radic Biol Med       Date:  2008-03-27       Impact factor: 7.376

4.  Processing of abasic DNA clusters in hApeI-silenced primary fibroblasts exposed to low doses of X-irradiation.

Authors:  Prolay Das; Betsy M Sutherland
Journal:  J Biosci       Date:  2011-03       Impact factor: 1.826

Review 5.  The cysteine proteome.

Authors:  Young-Mi Go; Joshua D Chandler; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2015-04-03       Impact factor: 7.376

Review 6.  Redox signaling in cardiovascular health and disease.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Free Radic Biol Med       Date:  2013-04-11       Impact factor: 7.376

Review 7.  Metabolic regulation of oxygen and redox homeostasis by p53: lessons from evolutionary biology?

Authors:  Jie Zhuang; Wenzhe Ma; Cory U Lago; Paul M Hwang
Journal:  Free Radic Biol Med       Date:  2012-07-25       Impact factor: 7.376

8.  Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells.

Authors:  Carlo Vascotto; Laura Cesaratto; Leo A H Zeef; Marta Deganuto; Chiara D'Ambrosio; Andrea Scaloni; Milena Romanello; Giuseppe Damante; Giulio Taglialatela; Daniela Delneri; Mark R Kelley; Sankar Mitra; Franco Quadrifoglio; Gianluca Tell
Journal:  Proteomics       Date:  2009-02       Impact factor: 3.984

9.  Phenotype-dependent apoptosis signalling in mesothelioma cells after selenite exposure.

Authors:  Gustav Nilsonne; Eric Olm; Adam Szulkin; Filip Mundt; Agnes Stein; Branka Kocic; Anna-Klara Rundlöf; Aristi P Fernandes; Mikael Björnstedt; Katalin Dobra
Journal:  J Exp Clin Cancer Res       Date:  2009-06-29

10.  JS-K, a nitric oxide prodrug, has enhanced cytotoxicity in colon cancer cells with knockdown of thioredoxin reductase 1.

Authors:  Kornelia Edes; Pamela Cassidy; Paul J Shami; Philip J Moos
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.